Vireo Health to Report First Quarter 2021 Results on May 14, 2021
Vireo Health International, a science-focused cannabis company, will announce its financial results for Q1 2021 on May 14, 2021, before market opens.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Vireo Health International, a science-focused cannabis company, will announce its financial results for Q1 2021 on May 14, 2021, before market opens. The conference call will occur at 8:30 a.m. ET on the same day, allowing stakeholders to gain insights into the company's performance. Interested participants can register for the call via a specific link. Vireo operates in eight markets and manages 16 dispensaries, aiming for efficiency and innovation in cannabis production. For more details, visit vireohealth.com.
Details
News Market Reaction – VREOF
The recorded move for VREOF in the trading session of this news was +2.64%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MINNEAPOLIS, May 4, 2021 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CSE: VREO, OTCQX: VREOF), the leading physician-founded, science-focused multi-state cannabis company, today announced that it will report financial results for its first quarter ended March 31, 2021 on Friday, May 14, 2021 before the market opens.
The Company will hold a conference call and webcast to discuss its business and financial results that same day at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). Interested parties may register to attend the call via this link: http://www.directeventreg.com/registration/event/2254847.
Upon registration, each participant will be provided with call details and a registrant ID for Vireo's conference ID number 2254847. A live audio webcast of the call will also be available in the Events & Presentations section of Vireo's website at https://investors.vireohealth.com/events-and-presentations/default.aspx. A webcast replay will be made available for one year on Vireo's website.
About Vireo Health International, Inc.
Vireo Health International, Inc. is a physician-led cannabis company focused on bringing the best of technology, science, and engineering to the cannabis industry. Vireo manufactures proprietary, branded cannabis products in environmentally friendly facilities, state-of-the-art cultivation sites and distributes its products through its growing network of Green Goods™ and other retail locations and third-party dispensaries. Vireo's team of more than 400 employees, led by scientists, engineers, and cultivation experts, is focused on efficiency and the creation of best-in-class products, while driving scientific innovation within the cannabis industry and developing meaningful intellectual property. Today, Vireo is licensed to grow and/or process cannabis in eight markets and operates 16 dispensaries nationwide. For more information about Vireo Health, please visit www.vireohealth.com.
Contact Information
Investor Inquiries
Sam Gibbons
Vice President, Investor Relations
samgibbons@vireohealth.com
(612) 314-8995
Media Inquiries
Albe Zakes
Vice President, Corporate Communications
albezakes@vireohealth.com
(267) 221-4800
View original content to download multimedia:http://www.prnewswire.com/news-releases/vireo-health-to-report-first-quarter-2021-results-on-may-14-2021-301282985.html
SOURCE Vireo Health International, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.